drugset / Trial / NCT05163535
Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA®
RandomizedParallel-groupOpen-labelTreatment
Summary
Open labelled, randomized study to evaluate the efficacy, safety and dose selection of VM-1500A-LAI drug in HIV-infected patients transferred from previous stable therapy (NNRTI + 2NRTI), including ELPIDA®.
Timeline
- Start
- 2021-01-19
- Primary completion
- 2021-08-03
- Completion
- 2021-08-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DEPULFAVIRINE | Small molecule | 600 mg | Intramuscular |
| Subject | DEPULFAVIRINE | Small molecule | 900 mg | Intramuscular |
| Subject | DEPULFAVIRINE | Small molecule | 1200 mg | Intramuscular |